TUI1:XETRTUI AG Analysis
Data as of 2026-09-01 - not real-time
€6.88
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
TUI AG is priced at €6.88, and its moving averages give no clean directional read — the structure is neutral. It has gained 1.1% over the past 30 days. RSI sits at 38.6, which reads as approaching oversold, and MACD momentum is bearish. The recent range runs from support at €6.86 up to resistance at €7.83.
On valuation the read is undervalued — an earnings multiple of 6.3, absent a reliable peer benchmark. Consensus targets land 44.8% above where the shares trade now. Revenue is contracting at 6.1% on a 2.5% profit margin. The 1.39% dividend yield looks covered by current payout levels.
Risk comes out at 6 of a possible 10, a elevated reading. With 30-day volatility of 29.0%, a beta of 0.28 and a maximum drawdown of 34.8%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
The horizons line up on hold — conviction 1 out of 10.
On valuation the read is undervalued — an earnings multiple of 6.3, absent a reliable peer benchmark. Consensus targets land 44.8% above where the shares trade now. Revenue is contracting at 6.1% on a 2.5% profit margin. The 1.39% dividend yield looks covered by current payout levels.
Risk comes out at 6 of a possible 10, a elevated reading. With 30-day volatility of 29.0%, a beta of 0.28 and a maximum drawdown of 34.8%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
The horizons line up on hold — conviction 1 out of 10.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Trading below the 200-day average of 7.56
- MACD momentum is negative
- Maximum drawdown of 34.8%
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- Trading below the 200-day average of 7.56
- Analyst targets imply +44.8% versus the current price
- MACD momentum is negative
Long Term
> 3 yearsNeutral
Model confidence: 1/10
Key Factors
- Analyst targets imply +44.8% versus the current price
- Revenue contracting at -6.1%
- Negative free cash flow
Key Metrics & Analysis
Financial Health
Revenue Growth-6.10%
Profit Margin2.53%
P/E Ratio6.3
ROE35.74%
ROA2.57%
Debt/Equity160.57
P/B Ratio1.9
Op. Cash Flow€1.5B
Free Cash Flow€-596587520
Technical Analysis
TrendNeutral
RSI38.6
Support€6.86
Resistance€7.83
MA 20€7.23
MA 50€7.21
MA 200€7.56
MACDBearish
VolumeStable
Fear & Greed Index94
Valuation
Fair Value€22.41
Target Price€9.96
Upside/Downside44.75%
GradeUndervalued
TypeValue
Dividend Yield1.39%
Risk Assessment
Beta0.28
Volatility28.95%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.